First study of “off-the-shelf” allogeneic stem-cell product for acute …
Hare says that use of allogeneic human MSCs has a number of important advantages over autologous bone-marrow mononuclear cells (BMCs), which have traditionally been employed in clinical trials for this indication. The new trial “serves as a benchmark …
[Read the full article here]Related News:
REVIEW: Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in First Complete Remission: Systematic Review …
Delayed stem cell therapy following heart attack is safe but not effective
New perspectives in human stem cell therapeutic research